2021 Vol.39, N°2 - Suppl.129 - Table of contents
Vasculitis 2021
One year in review
CER14754
2021,39,2,Suppl.129
Pg. 0003-0012
Free to view
One year in review 2021: systemic vasculitis
F. Ferro, L. Quartuccio, S. Monti, P. Delvino, F. Di Cianni, S. Fonzetti, G. La Rocca, C. Posarelli, E. Treppo, R. Talarico, C. Baldini
DOI: https://doi.org/10.55563/clinexprheumatol/v1tpfo
F. Ferro, L. Quartuccio, S. Monti, P. Delvino, F. Di Cianni, S. Fonzetti, G. La Rocca, C. Posarelli, E. Treppo, R. Talarico, C. Baldini
DOI: https://doi.org/10.55563/clinexprheumatol/v1tpfo
Aetiopathogenesis
CER13608
2021,39,2,Suppl.129
Pg. 0013-0020
Free to view
TIM-3 regulates the NETs-mediated dendritic cell activation in myeloperoxidase-ANCA-associated vasculitis
B. Su, X. Mao, B. Yin, C. Chen, M. Zhang, T. Cui, Y. Hao
DOI: https://doi.org/10.55563/clinexprheumatol/6y0bjb
B. Su, X. Mao, B. Yin, C. Chen, M. Zhang, T. Cui, Y. Hao
DOI: https://doi.org/10.55563/clinexprheumatol/6y0bjb
CER14266
2021,39,2,Suppl.129
Pg. 0021-0026
Free to view
The presence of both HLA-DRB1[*]04:01 and HLA-B[*]15:01 increases the susceptibility to cranial and extracranial giant cell arteritis
D. Prieto-Peña, S. Remuzgo-Martínez, J.G. Ocejo-Vinyals, B. Atienza-Mateo, F. Genre, A. Muñoz-Jimenez, F. Ortiz-Sanjuán, S. Romero-Yuste, C. Moriano, E. Galindez-Agirregoikoa, I. Calvo, N. Ortego-Centeno, N. Álvarez-Rivas, J.A. Miranda-Filloy, I. Llorente, J. García-García, R. Blanco, O. Gualillo, J. Martin, S. Castañeda, R. Lopez-Mejías, M.A. González-Gay
DOI: https://doi.org/10.55563/clinexprheumatol/nn15lt
D. Prieto-Peña, S. Remuzgo-Martínez, J.G. Ocejo-Vinyals, B. Atienza-Mateo, F. Genre, A. Muñoz-Jimenez, F. Ortiz-Sanjuán, S. Romero-Yuste, C. Moriano, E. Galindez-Agirregoikoa, I. Calvo, N. Ortego-Centeno, N. Álvarez-Rivas, J.A. Miranda-Filloy, I. Llorente, J. García-García, R. Blanco, O. Gualillo, J. Martin, S. Castañeda, R. Lopez-Mejías, M.A. González-Gay
DOI: https://doi.org/10.55563/clinexprheumatol/nn15lt
CER14514
2021,39,2,Suppl.129
Pg. 0027-0031
Free to view
Bowman’s capsule rupture links glomerular damage to tubulointerstitial inflammation in ANCA-associated glomerulonephritis
S. Hakroush, D. Tampe, P. Korsten, P. Ströbel, B. Tampe
DOI: https://doi.org/10.55563/clinexprheumatol/7eol6d
S. Hakroush, D. Tampe, P. Korsten, P. Ströbel, B. Tampe
DOI: https://doi.org/10.55563/clinexprheumatol/7eol6d
Clinical aspects
CER13268
2021,39,2,Suppl.129
Pg. 0032-0038
Free to view
Is Takayasu's arteritis more severe in children?
E.C. Bolek, U. Kaya Akca, A. Sari, E. Sag, S. Demir, L. Kilic, Y.Z. Sener, H.H. Aykan, E.B. Kaya, Y. Bilginer, A. Akdogan, S. Kiraz, O. Karadag, S. Ozen
DOI: https://doi.org/10.55563/clinexprheumatol/kr357t
E.C. Bolek, U. Kaya Akca, A. Sari, E. Sag, S. Demir, L. Kilic, Y.Z. Sener, H.H. Aykan, E.B. Kaya, Y. Bilginer, A. Akdogan, S. Kiraz, O. Karadag, S. Ozen
DOI: https://doi.org/10.55563/clinexprheumatol/kr357t
CER13406
2021,39,2,Suppl.129
Pg. 0039-0045
Free to view
Evaluating renal outcome of ANCA-associated renal vasculitis: comparative study of two histopathological scoring systems
X.-N. An, Z.-N. Wei, X.-Y. Yao, J. Xu, W.-T. Qian, X.-X. Pan, P.-Y. Shen, H. Shi, W. Zhang, X.-N. Chen, N. Chen, Y.-X. Chen
DOI: https://doi.org/10.55563/clinexprheumatol/24ep0c
X.-N. An, Z.-N. Wei, X.-Y. Yao, J. Xu, W.-T. Qian, X.-X. Pan, P.-Y. Shen, H. Shi, W. Zhang, X.-N. Chen, N. Chen, Y.-X. Chen
DOI: https://doi.org/10.55563/clinexprheumatol/24ep0c
CER13709
2021,39,2,Suppl.129
Pg. 0046-0051
Free to view
Factors associated with radiographic progression in patients with Takayasu's arteritis
S. Lee, Y. Eun, H. Kim, J. Lee, E.-M. Koh, D.-K. Kim, H.-S. Cha
DOI: https://doi.org/10.55563/clinexprheumatol/4566pe
S. Lee, Y. Eun, H. Kim, J. Lee, E.-M. Koh, D.-K. Kim, H.-S. Cha
DOI: https://doi.org/10.55563/clinexprheumatol/4566pe
CER14054
2021,39,2,Suppl.129
Pg. 0052-0055
Free to view
Flare of a mixed cryoglobulinaemic vasculitis after obinutuzumab infusion
G. Martin De Fremont, A. Chiron, R. Krzysiek, S. Hacein-Bey-Abina, X. Mariette, G. Nocturne
DOI: https://doi.org/10.55563/clinexprheumatol/rit83o
G. Martin De Fremont, A. Chiron, R. Krzysiek, S. Hacein-Bey-Abina, X. Mariette, G. Nocturne
DOI: https://doi.org/10.55563/clinexprheumatol/rit83o
CER14028
2021,39,2,Suppl.129
Pg. 0056-0061
Free to view
Infection versus cardiovascular disease as leading causes of hospitalisations and associated mortality in vasculitis in the U.S.: a national study
J.A. Singh
DOI: https://doi.org/10.55563/clinexprheumatol/ammhi6
J.A. Singh
DOI: https://doi.org/10.55563/clinexprheumatol/ammhi6
Diagnosis
CER13247
2021,39,2,Suppl.129
Pg. 0062-0068
Free to view
Subphenotypes of ANCA-associated vasculitis identified by latent class analysis
K. Wójcik, G. Biedroń, K. Wawrzycka-Adamczyk, S. Bazan-Socha, A. Ćmiel, Z. Zdrojewski, A. Masiak, Z. Czuszyńska, M. Majdan, R. Jeleniewicz, M. Klinger, M. Krajewska, M. Kusztal, M. Brzosko, B. Iwona, A. Dębska-Ślizień, H. Storoniak, B. Bułło-Piontecka, W. Tłustochowicz, J. Kur-Zalewska, M. Wisłowska, M. Madej, A. Hawrot-Kawecka, P. Głuszko, M. Stasiek, E. Kucharz, J. Musiał
DOI: https://doi.org/10.55563/clinexprheumatol/d01o72
K. Wójcik, G. Biedroń, K. Wawrzycka-Adamczyk, S. Bazan-Socha, A. Ćmiel, Z. Zdrojewski, A. Masiak, Z. Czuszyńska, M. Majdan, R. Jeleniewicz, M. Klinger, M. Krajewska, M. Kusztal, M. Brzosko, B. Iwona, A. Dębska-Ślizień, H. Storoniak, B. Bułło-Piontecka, W. Tłustochowicz, J. Kur-Zalewska, M. Wisłowska, M. Madej, A. Hawrot-Kawecka, P. Głuszko, M. Stasiek, E. Kucharz, J. Musiał
DOI: https://doi.org/10.55563/clinexprheumatol/d01o72
CER13559
2021,39,2,Suppl.129
Pg. 0069-0075
Free to view
Evidence for uncoupling of clinical and 18-FDG activity of PET/CT scan improvement in tocilizumab-treated patients with large-vessel giant cell arteritis
D. Prieto Peña, I. Martínez-Rodríguez, B. Atienza-Mateo, M. Calderón-Goercke, I. Banzo, M.C. González-Vela, S. Castañeda, J. Llorca, M.Á. González-Gay, R. Blanco
DOI: https://doi.org/10.55563/clinexprheumatol/mjm8fr
D. Prieto Peña, I. Martínez-Rodríguez, B. Atienza-Mateo, M. Calderón-Goercke, I. Banzo, M.C. González-Vela, S. Castañeda, J. Llorca, M.Á. González-Gay, R. Blanco
DOI: https://doi.org/10.55563/clinexprheumatol/mjm8fr
CER13356
2021,39,2,Suppl.129
Pg. 0076-0082
Free to view
18-FDG PET for large vessel vasculitis diagnosis and follow-up
F. Angelotti, R. Capecchi, A. Giorgetti, P.A. Erba, D. Genovesi, M. Emdin, A. Barison, L. Manca, V. Rocchi, P. Migliorini, A. Tavoni
DOI: https://doi.org/10.55563/clinexprheumatol/3cneda
F. Angelotti, R. Capecchi, A. Giorgetti, P.A. Erba, D. Genovesi, M. Emdin, A. Barison, L. Manca, V. Rocchi, P. Migliorini, A. Tavoni
DOI: https://doi.org/10.55563/clinexprheumatol/3cneda
CER13564
2021,39,2,Suppl.129
Pg. 0083-0087
Free to view
Autoantibody profile in eosinophilic granulomatosis and polyangiitis: predominance of anti-alpha-enolase antibodies
K. Laskari, B. Hellmich, G. Adamus, E. Csernok
DOI: https://doi.org/10.55563/clinexprheumatol/08k9af
K. Laskari, B. Hellmich, G. Adamus, E. Csernok
DOI: https://doi.org/10.55563/clinexprheumatol/08k9af
CER13883
2021,39,2,Suppl.129
Pg. 0088-0093
Free to view
Pan-immune-inflammation value at diagnosis independently predicts all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis
L.E. Lee, S.S. Ahn, J.Y. Pyo, J.J. Song, Y.-B. Park, S.-W. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/m46d0v
L.E. Lee, S.S. Ahn, J.Y. Pyo, J.J. Song, Y.-B. Park, S.-W. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/m46d0v
CER13791
2021,39,2,Suppl.129
Pg. 0094-0100
Free to view
D-dimer predicts poor hospitalisation outcomes in patients with antineutrophil cytoplasmic autoantibody-associated vasculitis
J.Y. Pyo, B. Yoo, M. Kwon, W.H. Bae, S.J. Byun, S.-W. Lee, Y.-B. Park, J.J. Song
DOI: https://doi.org/10.55563/clinexprheumatol/4nlfpe
J.Y. Pyo, B. Yoo, M. Kwon, W.H. Bae, S.J. Byun, S.-W. Lee, Y.-B. Park, J.J. Song
DOI: https://doi.org/10.55563/clinexprheumatol/4nlfpe
CER14166
2021,39,2,Suppl.129
Pg. 0101-0106
Free to view
The value of ultrasonography combined with clinical features for predicting carotid imaging progression of Takayasu's arteritis: a prospective cohort study
L.-Y. Ma, C.-L. Li, R.-Y. Chen, X.-M. Dai, Z.-F. Ji, H.-Y. Chen, H. Han, B.-J. Huang, Y. Sun, L.-D. Jiang
DOI: https://doi.org/10.55563/clinexprheumatol/1o86of
L.-Y. Ma, C.-L. Li, R.-Y. Chen, X.-M. Dai, Z.-F. Ji, H.-Y. Chen, H. Han, B.-J. Huang, Y. Sun, L.-D. Jiang
DOI: https://doi.org/10.55563/clinexprheumatol/1o86of
CER14486
2021,39,2,Suppl.129
Pg. 0107-0113
Free to view
Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis
S. Monti, M. Felicetti, P. Delvino, R. Padoan, A. Berti, G. Paolazzi, G. Brunori, F. Schiavon, R. Caporali, C. Montecucco
DOI: https://doi.org/10.55563/clinexprheumatol/50919f
S. Monti, M. Felicetti, P. Delvino, R. Padoan, A. Berti, G. Paolazzi, G. Brunori, F. Schiavon, R. Caporali, C. Montecucco
DOI: https://doi.org/10.55563/clinexprheumatol/50919f
Treatment
CER13385
2021,39,2,Suppl.129
Pg. 0114-0118
Free to view
Efficacy of leflunomide in the treatment of vasculitis
N. Mustapha, L. Barra, S. Carette, D. Cuthbertson, N.A. Khalidi, C.L. Koening, C.A. Langford, C.A. Mcalear, N. Milman, L.W. Moreland, P.A. Monach, P. Seo, U. Specks, A.G. Sreih, S.Y. Ytterberg, P.A. Merkel, C. Pagnoux
on behalf of the Canadian Vasculitis Research Network (CanVasc) and Vasculitis Clinical Research Consortium (VCRC)
DOI: https://doi.org/10.55563/clinexprheumatol/ve38dj
N. Mustapha, L. Barra, S. Carette, D. Cuthbertson, N.A. Khalidi, C.L. Koening, C.A. Langford, C.A. Mcalear, N. Milman, L.W. Moreland, P.A. Monach, P. Seo, U. Specks, A.G. Sreih, S.Y. Ytterberg, P.A. Merkel, C. Pagnoux
on behalf of the Canadian Vasculitis Research Network (CanVasc) and Vasculitis Clinical Research Consortium (VCRC)
DOI: https://doi.org/10.55563/clinexprheumatol/ve38dj
CER13891
2021,39,2,Suppl.129
Pg. 0119-0124
Free to view
Assessment of glucocorticoid tapering in large vessel and anti-neutrophil cytoplasmic antibody-associated vasculitides
A. Mendel, D. Ennis, S. Carette, C. Pagnoux
DOI: https://doi.org/10.55563/clinexprheumatol/6spy2c
A. Mendel, D. Ennis, S. Carette, C. Pagnoux
DOI: https://doi.org/10.55563/clinexprheumatol/6spy2c
CER13992
2021,39,2,Suppl.129
Pg. 0125-0128
Free to view
An agent-to-agent real life comparison study of tocilizumab versus abatacept in giant cell arteritis
D. Rossi, I. Cecchi, S. Sciascia, C. Naretto, M. Alpa, D. Roccatello
DOI: https://doi.org/10.55563/clinexprheumatol/l0hd9v
D. Rossi, I. Cecchi, S. Sciascia, C. Naretto, M. Alpa, D. Roccatello
DOI: https://doi.org/10.55563/clinexprheumatol/l0hd9v
CER14071
2021,39,2,Suppl.129
Pg. 0129-0134
Free to view
Failure of first anti-TNF agent in Takayasu's arteritis: to switch or to swap?
C. Campochiaro, A. Tomelleri, E. Galli, E. Cocchiara, S. Sartorelli, F. Muratore, C. Malattia, R. Caorsi, M.G. Catanoso, E. Baldissera, A. Ravelli, C. Salvarani, L. Dagna
DOI: https://doi.org/10.55563/clinexprheumatol/1xi8ag
C. Campochiaro, A. Tomelleri, E. Galli, E. Cocchiara, S. Sartorelli, F. Muratore, C. Malattia, R. Caorsi, M.G. Catanoso, E. Baldissera, A. Ravelli, C. Salvarani, L. Dagna
DOI: https://doi.org/10.55563/clinexprheumatol/1xi8ag
CER13831
2021,39,2,Suppl.129
Pg. 0135-0141
Free to view
The effects of biological agents on vascular structural lesions in Takayasu's arteritis
F. Erbasan, İ. Uçar, B. Aslan, V. Yazisiz, M.E. Terzioğlu
DOI: https://doi.org/10.55563/clinexprheumatol/z6drbj
F. Erbasan, İ. Uçar, B. Aslan, V. Yazisiz, M.E. Terzioğlu
DOI: https://doi.org/10.55563/clinexprheumatol/z6drbj
CER14269
2021,39,2,Suppl.129
Pg. 0142-0148
Free to view
Protective effect of different doses of trimethoprim-sulfamethoxazole prophylaxis for early severe infections among patients with antineutrophil cytoplasmic autoantibody-associated vasculitis
D. Waki, K. Nishimura, T. Yoshida, N. Tanaka, K. Mizukawa, M. Fukushima, O. Iri, M. Anegawa, H. Murabe, T. Yokota
DOI: https://doi.org/10.55563/clinexprheumatol/p34lkr
D. Waki, K. Nishimura, T. Yoshida, N. Tanaka, K. Mizukawa, M. Fukushima, O. Iri, M. Anegawa, H. Murabe, T. Yokota
DOI: https://doi.org/10.55563/clinexprheumatol/p34lkr
CER14622
2021,39,2,Suppl.129
Pg. 0149-0154
Free to view
Provisional recommendations for SARS-CoV-2 vaccination in patients with cryoglobulinaemic vasculitis
S. Scarpato, M. Sebastiani, L. Quartuccio, P. Marson, P. Fraticelli, L. Castelnovo, M. Visentini, M. Candela, C. Mazzaro, F. Saccardo, P. Pioltelli, M. Casato, D. Filippini, G. Monti, M. Galli
on behalf of the Italian Group for the Study of Cryoglobulinaemia (GISC)
DOI: https://doi.org/10.55563/clinexprheumatol/2v6v5j
S. Scarpato, M. Sebastiani, L. Quartuccio, P. Marson, P. Fraticelli, L. Castelnovo, M. Visentini, M. Candela, C. Mazzaro, F. Saccardo, P. Pioltelli, M. Casato, D. Filippini, G. Monti, M. Galli
on behalf of the Italian Group for the Study of Cryoglobulinaemia (GISC)
DOI: https://doi.org/10.55563/clinexprheumatol/2v6v5j
CER14512
2021,39,2,Suppl.129
Pg. 0155-0160
Free to view
A French cohort of patients with giant cell arteritis: glucocorticoid treatment and its associated side effects
S. Perrineau, T. Ghesquière, P. Charles, R. Paule, M. Samson, M. Gayraud, A. Chauvin, B. Terrier, L. Guillevin, B. Bonnotte, L. Mouthon, A. Régent
for the French Vasculitis Study Group (FVSG)
DOI: https://doi.org/10.55563/clinexprheumatol/0nd4kk
S. Perrineau, T. Ghesquière, P. Charles, R. Paule, M. Samson, M. Gayraud, A. Chauvin, B. Terrier, L. Guillevin, B. Bonnotte, L. Mouthon, A. Régent
for the French Vasculitis Study Group (FVSG)
DOI: https://doi.org/10.55563/clinexprheumatol/0nd4kk
CER14336
2021,39,2,Suppl.129
Pg. 0161-0170
Free to view
Curcumin alleviates inflammation in Takayasu’s arteritis by blocking CCL2 overexpression in adventitial fibroblasts
S. Wu, X. Kong, Y. Wang, X. Fan, Q. Huang, R. Chen, W. Yu, L. Ma, Y. Sun, L. Jiang
DOI: https://doi.org/10.55563/clinexprheumatol/72an1a
S. Wu, X. Kong, Y. Wang, X. Fan, Q. Huang, R. Chen, W. Yu, L. Ma, Y. Sun, L. Jiang
DOI: https://doi.org/10.55563/clinexprheumatol/72an1a
Review
CER13372
2021,39,2,Suppl.129
Pg. 0171-0179
Free to view
Cryoglobulins: putative effectors of adaptive immune response
U. Basile, C. Napodano, M. Marino, F. Gulli, S. Colantuono, M. Casato, K. Pocino, V. Basile, L. Todi, G.L. Rapaccini, M. Visentini
DOI: https://doi.org/10.55563/clinexprheumatol/keip4u
U. Basile, C. Napodano, M. Marino, F. Gulli, S. Colantuono, M. Casato, K. Pocino, V. Basile, L. Todi, G.L. Rapaccini, M. Visentini
DOI: https://doi.org/10.55563/clinexprheumatol/keip4u
Letters to the Editor
CER13553
2021,39,2,Suppl.129
Pg. 0180-0181
Free to view
A new focus on thyrosine kinases inhibitors in eosinophilic granulomatosis with polyangiitis
P. Triggianese, A. D'antonio, P. Conigliaro, F. Buccisano, G.L. Fonti, M.S. Chimenti, R. Perricone
DOI: https://doi.org/10.55563/clinexprheumatol/rrjt9m
P. Triggianese, A. D'antonio, P. Conigliaro, F. Buccisano, G.L. Fonti, M.S. Chimenti, R. Perricone
DOI: https://doi.org/10.55563/clinexprheumatol/rrjt9m
CER13302
2021,39,2,Suppl.129
Pg. 0182-0183
Free to view
Expansion of CD161 expressing CD8+ single-positive and CD4+CD8+ double-positive PR3-specific T-cells in granulomatosis with polyangiitis
S. Klapa, A. Müller, A. Koch, P. Klenerman, G. Riemekasten, P. Lamprecht
DOI: https://doi.org/10.55563/clinexprheumatol/fevsoy
S. Klapa, A. Müller, A. Koch, P. Klenerman, G. Riemekasten, P. Lamprecht
DOI: https://doi.org/10.55563/clinexprheumatol/fevsoy
CER13660
2021,39,2,Suppl.129
Pg. 0184
Free to view
Comment on: Imaging is the major determinant in the assessment of disease activity in Takayasu’s arteritis by Kenar et al.
G. Li Cavoli, F. Finazzo, C. Tortorici, L. Bono, T.V. Li Cavoli, M. Finazzo, A. Ferrantelli
DOI: https://doi.org/10.55563/clinexprheumatol/7op9ya
G. Li Cavoli, F. Finazzo, C. Tortorici, L. Bono, T.V. Li Cavoli, M. Finazzo, A. Ferrantelli
DOI: https://doi.org/10.55563/clinexprheumatol/7op9ya
CER13777
2021,39,2,Suppl.129
Pg. 0185
Free to view
Reply to the comment on: Imaging is the major determinant in the assessment of disease activity in Takayasu’s arteritis by Li Cavoli et al.
G. Kenar, F. Önen
DOI: https://doi.org/10.55563/clinexprheumatol/lu16kv
G. Kenar, F. Önen
DOI: https://doi.org/10.55563/clinexprheumatol/lu16kv
CER13714
2021,39,2,Suppl.129
Pg. 0186
Free to view
Comment on: New therapeutics for ANCA-associated vasculitis: 10 years devoted to lessen toxicity by Rossi et al.
G. Li Cavoli, C. Tortorici, L. Bono, C. Giammarresi, G. Ferrantelli, T.V. Li Cavoli, A. Ferrantelli
DOI: https://doi.org/10.55563/clinexprheumatol/rym1op
G. Li Cavoli, C. Tortorici, L. Bono, C. Giammarresi, G. Ferrantelli, T.V. Li Cavoli, A. Ferrantelli
DOI: https://doi.org/10.55563/clinexprheumatol/rym1op
CER13782
2021,39,2,Suppl.129
Pg. 0187-0188
Free to view
An unusual presentation of giant cell arteritis in a middle-aged woman
E. Zampeli, C. Anagnostopoulos, H.M. Moutsopoulos
DOI: https://doi.org/10.55563/clinexprheumatol/ypay4j
E. Zampeli, C. Anagnostopoulos, H.M. Moutsopoulos
DOI: https://doi.org/10.55563/clinexprheumatol/ypay4j
CER13949
2021,39,2,Suppl.129
Pg. 0189
Free to view
Pneumocystis pneumonia in patients with giant cell arteritis treated with high dose steroids: is there an indication for prophylaxis?
B.P. Krijthe, E.G. Hogendoorn-Van zwienen, D. Van Zeben
DOI: https://doi.org/10.55563/clinexprheumatol/7e45qb
B.P. Krijthe, E.G. Hogendoorn-Van zwienen, D. Van Zeben
DOI: https://doi.org/10.55563/clinexprheumatol/7e45qb
CER13799
2021,39,2,Suppl.129
Pg. 0190
Free to view
Pleuroparenchymal fibroelastosis in interstitial lung disease with antineutrophil cytoplasmic antibody-associated vasculitis
E. Bargagli, E. Conticini, M.A. Mazzei, P. Cameli, S. Guerrini, M. D'alessandro, B. Frediani
Collaborator/s: L. Cantarini, F. Bellisai, L. Alderighi, E. Selvi, L. Bergantini
on behalf of Pleuroparenchymal Fibroelastosis (PPFE) Siena Unit, Italy.
DOI: https://doi.org/10.55563/clinexprheumatol/3jl4uf
E. Bargagli, E. Conticini, M.A. Mazzei, P. Cameli, S. Guerrini, M. D'alessandro, B. Frediani
Collaborator/s: L. Cantarini, F. Bellisai, L. Alderighi, E. Selvi, L. Bergantini
on behalf of Pleuroparenchymal Fibroelastosis (PPFE) Siena Unit, Italy.
DOI: https://doi.org/10.55563/clinexprheumatol/3jl4uf
CER14035
2021,39,2,Suppl.129
Pg. 0191-0192
Free to view
Henoch-Schönlein purpura with renal and gastrointestinal involvement in course of COVID-19: a case report
L. Barbetta, G. Filocamo, E. Passoni, F. Boggio, C. Folli, V. Monzani
DOI: https://doi.org/10.55563/clinexprheumatol/5epvob
L. Barbetta, G. Filocamo, E. Passoni, F. Boggio, C. Folli, V. Monzani
DOI: https://doi.org/10.55563/clinexprheumatol/5epvob
CER14220
2021,39,2,Suppl.129
Pg. 0193
Free to view
Interstitial lung disease in ANCA-associated vasculitides: another step forward
M. Sebastiani, A. Manfredi, P. Faverio, C. Salvarani, F. Luppi
DOI: https://doi.org/10.55563/clinexprheumatol/tpm0on
M. Sebastiani, A. Manfredi, P. Faverio, C. Salvarani, F. Luppi
DOI: https://doi.org/10.55563/clinexprheumatol/tpm0on
CER14217
2021,39,2,Suppl.129
Pg. 0194-0195
Free to view
Belatacept as maintenance therapy in kidney transplant recipients with ANCA-associated vasculitis
M. Martins, A. Morel, C. Laurent, N. Kamar, D. Anglicheau, M. Matignon, C. Vigneau, D. Guerrot, N. Chavarot, J.M. Chemouny
DOI: https://doi.org/10.55563/clinexprheumatol/7jue09
M. Martins, A. Morel, C. Laurent, N. Kamar, D. Anglicheau, M. Matignon, C. Vigneau, D. Guerrot, N. Chavarot, J.M. Chemouny
DOI: https://doi.org/10.55563/clinexprheumatol/7jue09
CER14428
2021,39,2,Suppl.129
Pg. 0196
Free to view
Comment on: Hypereosinophilic bronchiolitis in ANCA-associated vasculitis: where does it stand? by Sebastiani et al.
E. Bilgin, H. Oral, E. Damadoğlu, Ö. Karadağ
DOI: https://doi.org/10.55563/clinexprheumatol/yj41kj
E. Bilgin, H. Oral, E. Damadoğlu, Ö. Karadağ
DOI: https://doi.org/10.55563/clinexprheumatol/yj41kj
CER14503
2021,39,2,Suppl.129
Pg. 0197
Free to view
Reply to the comment on: Hypereosinophilic bronchiolitis in ANCA-associated vasculitis: where does it stand? by Bilgin et al.
M. Sebastiani, A. Manfredi, G. Cassone, C. Salvarani, F. Luppi
DOI: https://doi.org/10.55563/clinexprheumatol/onslav
M. Sebastiani, A. Manfredi, G. Cassone, C. Salvarani, F. Luppi
DOI: https://doi.org/10.55563/clinexprheumatol/onslav
CER14468
2021,39,2,Suppl.129
Pg. 0198
Free to view
Comment on: Development of intracranial vasculitis in giant cell arteritis during tocilizumab treatment by Naderi
M.J. Koster, K.J. Warrington, V.T. Lehman
DOI: https://doi.org/10.55563/clinexprheumatol/3k20me
M.J. Koster, K.J. Warrington, V.T. Lehman
DOI: https://doi.org/10.55563/clinexprheumatol/3k20me
CER14557
2021,39,2,Suppl.129
Pg. 0199-0200
Free to view
High incidence of giant cell arteritis during the COVID-19 pandemic: no causal relationship but possible involvement of stress
S. Parreau, E. Liozon, K.-H. Ly, A.-L. Fauchais, S. Hantz
DOI: https://doi.org/10.55563/clinexprheumatol/qsx4mt
S. Parreau, E. Liozon, K.-H. Ly, A.-L. Fauchais, S. Hantz
DOI: https://doi.org/10.55563/clinexprheumatol/qsx4mt